Hua Wu's Insider Trades & SAST Disclosures

Hua Wu's most recent trade in SAB Biotherapeutics Inc was a trade of 58,161 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 22, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
SAB Biotherapeutics Inc
Hua Wu SVP Research & Product Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2021 58,161 58,161 - - Employee Stock Option (right to buy)
SAB Biotherapeutics Inc
Hua Wu SVP Research & Product Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2021 32,191 32,191 - - Earnout Rights (Restricted Stock Units)
SAB Biotherapeutics Inc
Hua Wu SVP Research & Product Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2021 14,540 14,540 - - Employee Stock Option (right to buy)
SAB Biotherapeutics Inc
Hua Wu SVP Research & Product Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2021 6,979 6,979 - - Employee Stock Option (right to buy)
SAB Biotherapeutics Inc
Hua Wu SVP Research & Product Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2021 4,653 4,653 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades